133 related articles for article (PubMed ID: 26601881)
1. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer.
Kishi T; Nakamura A; Itasaka S; Shibuya K; Matsumoto S; Kanai M; Kodama Y; Takaori K; Mizowaki T; Hiraoka M
Pancreatology; 2015; 15(6):694-700. PubMed ID: 26601881
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
[TBL] [Abstract][Full Text] [Related]
4. Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.
Torgeson A; Lloyd S; Boothe D; Tao R; Whisenant J; Garrido-Laguna I; Cannon GM
Cancer; 2017 Oct; 123(19):3816-3824. PubMed ID: 28621885
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.
Mitsuyoshi T; Matsuo Y; Itou H; Shintani T; Iizuka Y; Kim YH; Mizowaki T
J Radiat Res; 2018 Jan; 59(1):50-57. PubMed ID: 29182777
[TBL] [Abstract][Full Text] [Related]
6. Impact of presence and degree of pretreatment weight loss in locally-advanced pancreatic cancer patients treated with definitive concurrent chemoradiotherapy.
Yildirim BA; Özdemir Y; Colakoglu T; Topkan E
Pancreatology; 2016; 16(4):599-604. PubMed ID: 27029854
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer.
Yoo T; Lee WJ; Woo SM; Kim TH; Han SS; Park SJ; Moon SH; Shin KH; Kim SS; Hong EK; Kim DY; Park JW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e623-30. PubMed ID: 21600705
[TBL] [Abstract][Full Text] [Related]
9. A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy.
Choi SH; Park SW; Seong J
Radiother Oncol; 2018 Nov; 129(2):340-346. PubMed ID: 30177371
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
11. ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer.
Watanabe T; Ueno H; Watabe Y; Hiraoka N; Morizane C; Itami J; Okusaka T; Miura N; Kakizaki T; Kakuya T; Kamita M; Tsuchida A; Nagakawa Y; Wilber H; Yamada T; Honda K
Br J Cancer; 2015 Feb; 112(4):704-13. PubMed ID: 25602965
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
[TBL] [Abstract][Full Text] [Related]
13. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
[TBL] [Abstract][Full Text] [Related]
14. Interferon-based Adjuvant Chemoradiation for Resected Pancreatic Head Cancer: Long-term Follow-up of the Virginia Mason Protocol.
Rocha FG; Hashimoto Y; Traverso LW; Dorer R; Kozarek R; Helton WS; Picozzi VJ
Ann Surg; 2016 Feb; 263(2):376-84. PubMed ID: 25775069
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
[TBL] [Abstract][Full Text] [Related]
16. Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Aziz A; Rink M; Gakis G; Kluth LA; Dechet C; Miller F; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Fisch M; Burger M; Fritsche HM
Urol Int; 2014; 93(3):352-60. PubMed ID: 25138778
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.
Arslan D; Tural D; Koca T; Tastekin D; Kaymak Cerkesli A; Basaran H; Gunduz S; Murat Tatli A; Sezgin Goksu S; Uysal M; Kargi A; Kargi B; Koral L; Ibrahim Bassorgun C; Unal D; Mutlu H; Senol Coskun H; Ozdogan M; Bozcuk H
J BUON; 2015; 20(2):573-9. PubMed ID: 26011352
[TBL] [Abstract][Full Text] [Related]
18. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
Wu M; Guo J; Guo L; Zuo Q
Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer.
Sui K; Okabayashi T; Shima Y; Morita S; Iwata J; Sumiyoshi T; Saisaka Y; Hata Y; Noda Y; Matsumoto M; Nishioka A; Iiyama T; Shimada Y
Br J Radiol; 2017 Jul; 90(1075):20170165. PubMed ID: 28590776
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
